Th-Vac® Platform: AI-Based in Silico Epitope Screening for CD4+ T Cell- Mediated mRNA Cancer Vaccine Immunotherapy
Time: 2:00 pm
day: Conference Day One
Details:
- Th-Vac® is an AI-powered system designed to help create mRNA cancer vaccines that activate CD4+ helper T cells
- Harnessing this technology to develop mRNA vaccines that can specifically target cancer associated antigens such as TROP2, PD-L1, IDO, and KRAS
- Addressing the current challenges in cancer immunotherapy and enhancing future treatment options
